NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung
Cancer (NSCLC) provide recommended management for patients with NSCLC, including …

Medicine (ACCME): NCCN designates this journal-based CME activity for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with …

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations
for management of disease in patients with NSCLC. These NCCN Guidelines Insights …

Worldwide over 1 million people die due to lung cancer each year. It is estimated that
cigarette smoking explains almost 90% of lung cancer risk in men and 70 to 80% in women. …

Purpose: A phase I study was conducted to determine safety, clinical efficacy, and antitumor
immune responses in patients with advanced non–small cell lung carcinoma (NSCLC) …

Altered metabolism is a hallmark of cancer growth, forming the conceptual basis for development
of metabolic therapies as cancer treatments. We performed in vivo metabolic profiling …

BACKGROUND The main objectives of this study were to identify the number of randomized
controlled trials (RCTs) including a patient‐reported outcome (PRO) endpoint across a wide …

Lung carcinogenesis is a complex process involving the acquisition of genetic mutations
that confer cancer development and the malignant phenotype, and is critically linked to …

The diagnostic definition of indeterminate lung nodules as malignant or benign poses a major
challenge for clinicians. We discovered a potential marker, the sodium-dependent glucose …

Purpose: As a transcriptional repressor of E-cadherin, Snail has predominantly been
associated with epithelial-mesenchymal transition, invasion, and metastasis. However, other …